Wilson Sonsini Goodrich & Rosati acted as the U.S. and Hong Kong counsel to Ascentage Pharma in the transaction. Ascentage Pharma Group International (Ascentage Pharma) (6855.HK)...
Takeda’s $75 Million Investment in Ascentage Pharma
Tenaya Therapeutics’ $75 Million Shares Offering
Wilson Sonsini Goodrich & Rosati advised Tenaya on the deal, while Davis Polk advised the joint book-running managers and representatives of the several underwriters. Clinical stage...
Roblox’s Senior Notes Offering
Wilson Sonsini Goodrich & Rosati advised Roblox on the deal. Simpson Thacher represented Morgan Stanley & Co. LLC, Goldman Sachs & Co. LLC and J.P. Morgan...
Savara Inc.’s $130 Million Public Offering
Wilson Sonsini Goodrich & Rosati advised Savara Inc. on the deal. Savara Inc., an orphan lung disease company, announced the closing of an underwritten public offering...